Joel M. Linden,Kori Wallace,Robert Alan Figler,Jayson M. Rieger
申请号：
US11673360
公开号：
US08178509B2
申请日:
2007.02.09
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention provides a therapeutic method for treating an inflammatory response caused by a sickle cell crisis, comprising administration of an effective amount of an A2A adenosine receptor agonist. Optionally, the method includes administration of a type IV PDE inhibitor (e.g., rolipram).
